Prevention and treatment of liver allograft antibody-mediated rejection and the role of the 'two-hit hypothesis'

Peter T.W. Kim, Anthony J. Demetris, Jacqueline G. O'Leary

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

Purpose of review The review outlines the diagnosis, prevention strategies, and possible treatment options for acute and chronic antibody-mediated rejection (AMR). Recent findings Although rare, severe acute AMR (aAMR) usually occurs in patients with high mean fluorescence intensity despite serial dilutions or high-titer preformed class I donor-specific alloantibodies (DSA). The diagnosis is suspected when allograft dysfunction occurs with DSA, diffuse C4d staining, and a microvascular injury, and may be aided by the aAMR score. However, the incidence of and treatment approach to combined T-cell-mediated rejection (TCMR) with DSA present and some but not all features of AMR is yet to be determined. Chronic liver allograft AMR is characterized by low-grade chronic inflammation and progressive fibrosis with DSA, the chronic AMR (cAMR) score may facilitate diagnosis. The 'two-hit' hypothesis, whereby a coexistent insult upregulates human leukocyte antigen class II target antigens on the microvascular endothelium, may explain why suboptimal donors with lower sensitization levels might suffer from acute AMR and those with chronic complications (e.g., recurrent original disease) might be more susceptible to chronic AMR. Although treatment algorithms are needed, prevention is preferable and at a minimum includes transfusion minimization, and medication adherence. Summary Severe acute AMR is rare but diagnosable, and there is need to determine the incidence of and optimal therapy for less severe combined AMR and TCMR. Chronic AMR is likely more common and of significant relevance to long-term allograft survival improvement. The two-hit hypothesis may help to explain the rarity of both findings and shed insight onto future prevention and treatment strategies.

Original languageEnglish (US)
Pages (from-to)209-218
Number of pages10
JournalCurrent Opinion in Organ Transplantation
Volume21
Issue number2
DOIs
StatePublished - Apr 1 2016

Fingerprint

Allografts
Antibodies
Liver
Isoantibodies
Tissue Donors
Therapeutics
Rejection (Psychology)
T-Lymphocytes
Medication Adherence
Histocompatibility Antigens Class II
Incidence
HLA Antigens
Endothelium
Fibrosis
Up-Regulation
Fluorescence
Staining and Labeling
Inflammation
Wounds and Injuries

Keywords

  • acute antibody-mediated rejection
  • chronic antibody-mediated rejection
  • donor-specific antibodies
  • outcomes
  • rejection

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation

Cite this

Prevention and treatment of liver allograft antibody-mediated rejection and the role of the 'two-hit hypothesis'. / Kim, Peter T.W.; Demetris, Anthony J.; O'Leary, Jacqueline G.

In: Current Opinion in Organ Transplantation, Vol. 21, No. 2, 01.04.2016, p. 209-218.

Research output: Contribution to journalReview article

@article{6e3f020789e646a3a68a275c8df24769,
title = "Prevention and treatment of liver allograft antibody-mediated rejection and the role of the 'two-hit hypothesis'",
abstract = "Purpose of review The review outlines the diagnosis, prevention strategies, and possible treatment options for acute and chronic antibody-mediated rejection (AMR). Recent findings Although rare, severe acute AMR (aAMR) usually occurs in patients with high mean fluorescence intensity despite serial dilutions or high-titer preformed class I donor-specific alloantibodies (DSA). The diagnosis is suspected when allograft dysfunction occurs with DSA, diffuse C4d staining, and a microvascular injury, and may be aided by the aAMR score. However, the incidence of and treatment approach to combined T-cell-mediated rejection (TCMR) with DSA present and some but not all features of AMR is yet to be determined. Chronic liver allograft AMR is characterized by low-grade chronic inflammation and progressive fibrosis with DSA, the chronic AMR (cAMR) score may facilitate diagnosis. The 'two-hit' hypothesis, whereby a coexistent insult upregulates human leukocyte antigen class II target antigens on the microvascular endothelium, may explain why suboptimal donors with lower sensitization levels might suffer from acute AMR and those with chronic complications (e.g., recurrent original disease) might be more susceptible to chronic AMR. Although treatment algorithms are needed, prevention is preferable and at a minimum includes transfusion minimization, and medication adherence. Summary Severe acute AMR is rare but diagnosable, and there is need to determine the incidence of and optimal therapy for less severe combined AMR and TCMR. Chronic AMR is likely more common and of significant relevance to long-term allograft survival improvement. The two-hit hypothesis may help to explain the rarity of both findings and shed insight onto future prevention and treatment strategies.",
keywords = "acute antibody-mediated rejection, chronic antibody-mediated rejection, donor-specific antibodies, outcomes, rejection",
author = "Kim, {Peter T.W.} and Demetris, {Anthony J.} and O'Leary, {Jacqueline G.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1097/MOT.0000000000000275",
language = "English (US)",
volume = "21",
pages = "209--218",
journal = "Current Opinion in Organ Transplantation",
issn = "1087-2418",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Prevention and treatment of liver allograft antibody-mediated rejection and the role of the 'two-hit hypothesis'

AU - Kim, Peter T.W.

AU - Demetris, Anthony J.

AU - O'Leary, Jacqueline G.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Purpose of review The review outlines the diagnosis, prevention strategies, and possible treatment options for acute and chronic antibody-mediated rejection (AMR). Recent findings Although rare, severe acute AMR (aAMR) usually occurs in patients with high mean fluorescence intensity despite serial dilutions or high-titer preformed class I donor-specific alloantibodies (DSA). The diagnosis is suspected when allograft dysfunction occurs with DSA, diffuse C4d staining, and a microvascular injury, and may be aided by the aAMR score. However, the incidence of and treatment approach to combined T-cell-mediated rejection (TCMR) with DSA present and some but not all features of AMR is yet to be determined. Chronic liver allograft AMR is characterized by low-grade chronic inflammation and progressive fibrosis with DSA, the chronic AMR (cAMR) score may facilitate diagnosis. The 'two-hit' hypothesis, whereby a coexistent insult upregulates human leukocyte antigen class II target antigens on the microvascular endothelium, may explain why suboptimal donors with lower sensitization levels might suffer from acute AMR and those with chronic complications (e.g., recurrent original disease) might be more susceptible to chronic AMR. Although treatment algorithms are needed, prevention is preferable and at a minimum includes transfusion minimization, and medication adherence. Summary Severe acute AMR is rare but diagnosable, and there is need to determine the incidence of and optimal therapy for less severe combined AMR and TCMR. Chronic AMR is likely more common and of significant relevance to long-term allograft survival improvement. The two-hit hypothesis may help to explain the rarity of both findings and shed insight onto future prevention and treatment strategies.

AB - Purpose of review The review outlines the diagnosis, prevention strategies, and possible treatment options for acute and chronic antibody-mediated rejection (AMR). Recent findings Although rare, severe acute AMR (aAMR) usually occurs in patients with high mean fluorescence intensity despite serial dilutions or high-titer preformed class I donor-specific alloantibodies (DSA). The diagnosis is suspected when allograft dysfunction occurs with DSA, diffuse C4d staining, and a microvascular injury, and may be aided by the aAMR score. However, the incidence of and treatment approach to combined T-cell-mediated rejection (TCMR) with DSA present and some but not all features of AMR is yet to be determined. Chronic liver allograft AMR is characterized by low-grade chronic inflammation and progressive fibrosis with DSA, the chronic AMR (cAMR) score may facilitate diagnosis. The 'two-hit' hypothesis, whereby a coexistent insult upregulates human leukocyte antigen class II target antigens on the microvascular endothelium, may explain why suboptimal donors with lower sensitization levels might suffer from acute AMR and those with chronic complications (e.g., recurrent original disease) might be more susceptible to chronic AMR. Although treatment algorithms are needed, prevention is preferable and at a minimum includes transfusion minimization, and medication adherence. Summary Severe acute AMR is rare but diagnosable, and there is need to determine the incidence of and optimal therapy for less severe combined AMR and TCMR. Chronic AMR is likely more common and of significant relevance to long-term allograft survival improvement. The two-hit hypothesis may help to explain the rarity of both findings and shed insight onto future prevention and treatment strategies.

KW - acute antibody-mediated rejection

KW - chronic antibody-mediated rejection

KW - donor-specific antibodies

KW - outcomes

KW - rejection

UR - http://www.scopus.com/inward/record.url?scp=84960433303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960433303&partnerID=8YFLogxK

U2 - 10.1097/MOT.0000000000000275

DO - 10.1097/MOT.0000000000000275

M3 - Review article

C2 - 26918881

AN - SCOPUS:84960433303

VL - 21

SP - 209

EP - 218

JO - Current Opinion in Organ Transplantation

JF - Current Opinion in Organ Transplantation

SN - 1087-2418

IS - 2

ER -